发明名称 ESTER COMPOUND AND MEDICAL USE THEREOF
摘要 <p>The present invention relates to a biphenyl compound represented by the formula (100) wherein R1Æ is hydrogen, C1-C6 alkyl, halogen, halo C1-C6 alkyl or C1-C6 alkoxy; R 2ÆÆÆ is hydrogen, C1-C6 alkyl, halogen, halo C1-C6 alkyl or C2-C6 alkenyl; R 3 " is -CON(R11a) (R12a) wherein R11a and R12a are each independently hydrogen, C1-C6 alkyl, optionally substituted C6-C14 aryl, optionally substituted C7-C16 aralkyl, C1-C6 alkoxy, or R11a and R12a may be taken together with the nitrogen to which they are attached to form in which p is an integer of 0 to 2; R4'is hydrogen, halogen, C1-C6 alkyl or halo C1-C6 alkyl; R50 is hydrogen, C1-C6 alkyl, optionally substituted C6-C14 aryl or optionally substituted C7-C16 aralkyl; and 1a is an integer of 1 to 3, or a prodrug thereof, or a pharmaceutically acceptable salt of either. The biphenyl compound of the present invention is an intermediate compound, which can be used as a starting compound for the end product, for example, pharmaceutically active compound, e.g. ester compound (1):</p>
申请公布号 SG165154(A1) 申请公布日期 2010.10.28
申请号 SG20060058796 申请日期 2003.02.28
申请人 JAPAN TOBACCO INC. 发明人 ATSUSHI HAGIWARA;YASUHIRO OHE;NAOYA ODANI;SHIZUE WATANABE;TAKU IKENOGAMI;TAKASHI KAWAI;KENYA MADONO;TOSHIO TANIGUCHI
分类号 A61K31/215;A61K31/216;A61K31/235;A61K31/24;A61K31/245;A61K31/277;A61K31/381;A61K31/397;A61K31/40;A61K31/4015;A61K31/404;A61K31/4184;A61K31/423;A61K31/426;A61K31/4402;A61K31/4406;A61K31/4418;A61K31/4453;A61K31/4468;A61K31/5375;A61P3/04;A61P3/06;A61P3/10;A61P9/00;C07C69/732;C07C69/76;C07C69/773;C07C69/88;C07C233/81;C07C235/06;C07C235/14;C07C235/16;C07C235/26;C07C235/30;C07C235/34;C07C235/40;C07C235/64;C07C235/84;C07C237/42;C07C311/04;C07D205/12;C07D207/09;C07D207/16;C07D207/40;C07D207/404;C07D209/08;C07D211/58;C07D213/55;C07D213/61;C07D213/82;C07D235/06;C07D263/58;C07D277/30;C07D277/56;C07D295/135;C07D295/192;C07D333/24;(IPC1-7):C07C69/732;C07C235/38;C07C235/36;C07D207/20;C07C255/57 主分类号 A61K31/215
代理机构 代理人
主权项
地址